Elanco Animal Health Incorporated (NYSE: ELAN)
Health Care · Pharmaceuticals · US
$22.78
-0.61% today · +14.2% 1Y
Elanco Animal Health Incorporated (NYSE: ELAN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.45B and employs 9,650 people.
Over the last twelve months the share price has gained 14.2%, trading between 19.40 and 27.98.
Tweenvest scores Elanco Animal Health Incorporated across four factors: quality 63/100, value 51/100, growth 32/100. Its strongest factor is quality.
ELAN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.45B
- Revenue (TTM)
- $5.02B
- P/E
- —
- EPS
- -0.41
- Dividend yield
- —
- Beta (5Y)
- 1.71
- 52-week high
- $27.98
- 52-week low
- $19.40
- Avg volume (3M)
- —
- Shares outstanding
- 499.62M
- Employees
- 9,650
- Next earnings
- —
About Elanco Animal Health Incorporated
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
- ISIN
- US28414H1032
- Founded
- 1954
- Listed since
- Sep 20, 2018
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Orion OyjHLSE: ORNBV | $12.51B | €82.30 | +3.39% |
| Sino Biopharmaceutical LimitedSEHK: 1177 | $12.28B | HK$5.41 | -1.37% |
| Recordati Industria Chimica e Farmaceutica S.p.A.BIT: REC | $12.15B | €52.95 | -0.09% |
| Zydus Lifesciences LimitedNSEI: ZYDUSLIFE | $11.52B | Rs1,117.50 | -2.46% |
| Laurus Labs LimitedNSEI: LAURUSLABS | $11.37B | Rs2,036.60 | +2.65% |
| Cipla LimitedNSEI: CIPLA | $10.86B | Rs1,301.00 | -3.20% |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.SHSE: 600436 | $10.79B | CN¥119.82 | +1.38% |
| Dr. Reddy's Laboratories LimitedBSE: 500124 | $10.29B | Rs1,195.10 | +1.28% |
Figures last refreshed Oct 11, 2026.